On Thursday, H.C. Wainwright analyst Swayampakula Ramakanth increased the price target for MediWound Ltd (NASDAQ: MDWD) shares to $31 from $25, while keeping a Buy rating on the stock.Currently ...

On Thursday, H.C. Wainwright analyst Swayampakula Ramakanth increased the price target for MediWound Ltd (NASDAQ: MDWD) shares to $31 from $25, while keeping a Buy rating on the stock.Currently ...

Image source: The Motley Fool. DATE Wednesday, May 21, 2025, at 8:30 a.m. EDT Read More: Earn up to $845 cash back this year just by changing how you pay at Costco! Learn more here. CALL ...

YAVNE, Israel, May 21, 2025 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced financial results for the ...

For instance, 78% of EscharEx patients achieved wound bed preparation, versus 38% of SANTYL, with a 33% wound closure rates compared to SANTYL’s 25%. Given these results, EscharEx has a strong ...